Last reviewed · How we verify
AMI MultiStem®
AMI MultiStem® is an investigational cell therapy developed by Healios K.K. for the treatment of acute myocardial infarction. It has completed a Phase 1 safety study and was part of a terminated Phase 2 trial. The therapy aims to reduce inflammation and promote tissue repair post-heart attack.
At a glance
| Generic name | AMI MultiStem® |
|---|---|
| Sponsor | Healios K.K. |
| Modality | Biologic |
| Phase | Phase 1 |